{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T14:27:01Z","timestamp":1786717621986,"version":"build-2736575974"},"reference-count":38,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Prev Med"],"published-print":{"date-parts":[[2016]]},"DOI":"10.4103\/2008-7802.184502","type":"journal-article","created":{"date-parts":[[2016,6,23]],"date-time":"2016-06-23T01:41:54Z","timestamp":1466646114000},"page":"88","source":"Crossref","is-referenced-by-count":20,"title":["Comparison of glibenclamide and insulin on neonatal outcomes in pregnant women with gestational diabetes"],"prefix":"10.4103","volume":"7","author":[{"given":"Farzaneh","family":"Saberi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitra","family":"Behrashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mansooreh","family":"Samimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tayyebeh","family":"Ghasemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Atoof","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/2008-7802.184502-1","first-page":"1","volume-title":"Treatments for gestational diabetes (Review)","author":"Alwan","year":"2009","journal-title":"Cochrane Libr"},{"key":"key-10.4103\/2008-7802.184502-2","first-page":"685","volume-title":"Diabetes in pregnancy","author":"McCance","year":"2015","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"key-10.4103\/2008-7802.184502-3","first-page":"S5","volume-title":"Report of the expert committee on the diagnosis and classification of diabetes mellitus","author":"Expert","year":"2003","journal-title":"Diabetes Care"},{"key":"key-10.4103\/2008-7802.184502-4","first-page":"S88","volume-title":"Gestational diabetes mellitus (Position Statement)","author":"American","year":"2004","journal-title":"Diabetes Care"},{"key":"key-10.4103\/2008-7802.184502-5","first-page":"B161","volume-title":"Summary and recommendations of the Fourth International Workshop-Conference on Gestational Diabetes Mellitus.The Organizing Committee","author":"Metzger","year":"1998","journal-title":"Diabetes Care"},{"key":"key-10.4103\/2008-7802.184502-6","first-page":"308","volume-title":"Glyburide for the treatment of gestational diabetes mellitus","author":"Kimber-Trojnar","year":"2008","journal-title":"Pharmacol Rep"},{"key":"key-10.4103\/2008-7802.184502-7","first-page":"209","volume-title":"Diabetes mellitus in pregnancy.What are the best treatment options?","author":"Reece","year":"1998","journal-title":"Drug Saf"},{"key":"key-10.4103\/2008-7802.184502-8","first-page":"1172","volume-title":"Insulin antibody response to a short course of human insulin therapy in women with gestational diabetes","author":"Balsells","year":"1997","journal-title":"Diabetes Care"},{"key":"key-10.4103\/2008-7802.184502-9","first-page":"145","volume-title":"Anti-insulin antibodies and birth weight in pregnancies complicated by diabetes","author":"Weiss","year":"1998","journal-title":"Early Hum Dev"},{"key":"key-10.4103\/2008-7802.184502-10","unstructured":"Canningham FG, Leveno KJ, Bloom SL, Catherine YS, Dashe JS, Hoffman BL, et al. Williams Obstetrics. 24 th ed. New York: McGraw-Hill; 2014."},{"key":"key-10.4103\/2008-7802.184502-11","first-page":"227","volume-title":"Oral hypoglycemic agents for gestational diabetes mellitus?","author":"Maymone","year":"2011","journal-title":"Expert Opin Drug Saf"},{"key":"key-10.4103\/2008-7802.184502-12","unstructured":"Mesdaghinia E, Samimi M, Homaei Z, Saberi F, Moosavi SG, Yaribakht M. Comparison of newborn outcomes in women with gestational diabetes mellitus treated with metformin or insulin: A randomised blinded trial. Int J Prev Med 2013;4:327-33."},{"key":"key-10.4103\/2008-7802.184502-13","doi-asserted-by":"crossref","unstructured":"Dhulkotia JS, Ola B, Fraser R, Farrell T. Oral hypoglycemic agents vs insulin in management of gestational diabetes: A systematic review and metaanalysis. Am J Obstet Gynecol 2010;203:457.e1-9.","DOI":"10.1016\/j.ajog.2010.06.044"},{"key":"key-10.4103\/2008-7802.184502-14","first-page":"262","volume-title":"Comparison of glyburide and insulin for the management of gestational diabetics with markedly elevated oral glucose challenge test and fasting hyperglycemia","author":"Ramos","year":"2007","journal-title":"J Perinatol"},{"key":"key-10.4103\/2008-7802.184502-15","first-page":"h102","volume-title":"Glibenclamide, metformin, and insulin for the treatment of gestational diabetes: A systematic review and meta-analysis","author":"Balsells","year":"2015","journal-title":"BMJ"},{"key":"key-10.4103\/2008-7802.184502-16","first-page":"129","volume-title":"Extralipid effects of hypolipidemic drugs - Why do clinical trials weakly support experimental data?","author":"Szkr\u00f3bka","year":"2007","journal-title":"Pharmacol Rep"},{"key":"key-10.4103\/2008-7802.184502-17","first-page":"1078","volume-title":"Changing the treatment of permanent neonatal diabetes mellitus from insulin to glibenclamide in a 4-month-old infant with KCNJ11 activating mutation","author":"Ilkhanipoor","year":"2013","journal-title":"Int J Prev Med","ISSN":"https:\/\/id.crossref.org\/issn\/2008-7802","issn-type":"print"},{"key":"key-10.4103\/2008-7802.184502-18","first-page":"S152","volume-title":"Comparison of oral glyburide with insulin for the management of gestational diabetes mellitus in Alaska Native women (abstract)","author":"Gilson","year":"2002","journal-title":"Am J Obstet Gynecol"},{"key":"key-10.4103\/2008-7802.184502-19","first-page":"51","volume-title":"Use of glyburide for the treatment of gestational diabetes: The San Antonio experience","author":"Conway","year":"2004","journal-title":"J Matern Fetal Neonatal Med"},{"key":"key-10.4103\/2008-7802.184502-20","first-page":"861","volume-title":"Designing pregnancy centered medications: Drugs which do not cross the human placenta","author":"Gedeon","year":"2006","journal-title":"Placenta"},{"key":"key-10.4103\/2008-7802.184502-21","first-page":"437","volume-title":"Potassium channel openers induce mitochondrial matrix volume changes via activation of ATP-sensitive K+channel","author":"Szewczyk","year":"1993","journal-title":"Pol J Pharmacol"},{"key":"key-10.4103\/2008-7802.184502-22","first-page":"724","volume-title":"Dose-dependent effects of glyburide on insulin secretion and glucose uptake in humans","author":"Groop","year":"1991","journal-title":"Diabetes Care"},{"key":"key-10.4103\/2008-7802.184502-23","first-page":"1320","volume-title":"Different effects of glyburide and glipizide on insulin secretion and hepatic glucose production in normal and NIDDM subjects","author":"Groop","year":"1987","journal-title":"Diabetes"},{"key":"key-10.4103\/2008-7802.184502-24","first-page":"483","volume-title":"Safety of glyburide for gestational diabetes: A meta-analysis of pregnancy outcomes","author":"Moretti","year":"2008","journal-title":"Ann Pharmacother"},{"key":"key-10.4103\/2008-7802.184502-25","first-page":"541","volume-title":"Glibenclamide in the treatment for gestational diabetes mellitus in a compared study to insulin","author":"Silva","year":"2007","journal-title":"Arq Bras Endocrinol Metabol"},{"key":"key-10.4103\/2008-7802.184502-26","first-page":"95","volume-title":"The use of glyburide in the management of gestational diabetes mellitus: A meta-analysis","author":"Zeng","year":"2014","journal-title":"Adv Med Sci"},{"key":"key-10.4103\/2008-7802.184502-27","first-page":"379","volume-title":"Treatment of gestational diabetes mellitus: Glyburide compared to subcutaneous insulin therapy and associated perinatal outcomes","author":"Cheng","year":"2012","journal-title":"J Matern Fetal Neonatal Med"},{"key":"key-10.4103\/2008-7802.184502-28","first-page":"989","volume-title":"Gestational diabetes: The consequences of not treating","author":"Langer","year":"2005","journal-title":"Am J Obstet Gynecol"},{"key":"key-10.4103\/2008-7802.184502-29","first-page":"1","volume-title":"Comparison of therapeutic effects of insulin and glibenclamide in gestational diabetes","author":"Zangeneh","year":"2014","journal-title":"IJOGI"},{"key":"key-10.4103\/2008-7802.184502-30","unstructured":"Cunningham FG, Leveno KJ, Bloom SL, Spong CY, Dashe JS, Hoffman BL, et al. Williams Obstetrics. 24 th ed. New York: McGraw Hill; 2014."},{"key":"key-10.4103\/2008-7802.184502-31","first-page":"118","volume-title":"Comparison of glyburide and insulin for the management of gestational diabetes in a large managed care organization","author":"Jacobson","year":"2005","journal-title":"Am J Obstet Gynecol"},{"key":"key-10.4103\/2008-7802.184502-32","first-page":"1147","volume-title":"Glyburide as treatment option for gestational diabetes mellitus","author":"Tempe","year":"2013","journal-title":"J Obstet Gynaecol Res"},{"key":"key-10.4103\/2008-7802.184502-33","first-page":"289","volume-title":"Correlation between macrosomia body indices and maternal fasting blood glucose","author":"Song","year":"2014","journal-title":"J Obstet Gynaecol"},{"key":"key-10.4103\/2008-7802.184502-34","first-page":"28","volume-title":"Oral hypoglycemic glibenclamide: Can it be a substitute to insulin in the management of gestational diabetes mellitus.A comparative study?","author":"Mukhopadhyay","year":"2012","journal-title":"J South Asian Fed Obstet Gynaecol"},{"key":"key-10.4103\/2008-7802.184502-35","first-page":"133","volume-title":"Is there a role for oral antihyperglycemics in gestational diabetes and type 2 diabetes during pregnancy?","author":"Homko","year":"2004","journal-title":"Treat Endocrinol"},{"key":"key-10.4103\/2008-7802.184502-36","first-page":"1134","volume-title":"A comparison of glyburide and insulin in women with gestational diabetes mellitus","author":"Langer","year":"2000","journal-title":"N Engl J Med"},{"key":"key-10.4103\/2008-7802.184502-37","first-page":"653","volume-title":"Comparative placental transport of oral hypoglycemic agents in humans: A model of human placental drug transfer","author":"Elliott","year":"1994","journal-title":"Am J Obstet Gynecol"},{"key":"key-10.4103\/2008-7802.184502-38","first-page":"270","volume-title":"Perfusion studies of glyburide transfer across the human placenta: Implications for fetal safety","author":"Kraemer","year":"2006","journal-title":"Am J Obstet Gynecol"}],"container-title":["International Journal of Preventive Medicine"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T13:26:45Z","timestamp":1786714005000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/2008-7802.184502"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016]]}},"alternative-id":["184502"],"URL":"https:\/\/doi.org\/10.4103\/2008-7802.184502","relation":{},"ISSN":["2008-7802"],"issn-type":[{"value":"2008-7802","type":"print"}],"subject":[],"published":{"date-parts":[[2016]]}}}